Skip to content

Clinical trials

Schizophrenia trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Hong Kong Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20083
20102
20132
20141
20151
20171
20182
20195
20202
20213
20221
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Not yet recruiting2
Recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Hong Kong Polytechnic University8
The University of Hong Kong7
Dr WANG Shumei3
Janssen Research & Development, LLC3
Chinese University of Hong Kong2
H. Lundbeck A/S2
AstraZeneca1
CHAN SAU MAN, SANDRA1
Hospital Authority, Hong Kong1
Kit Wa Chan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia31
Psychotic Disorders11
Cognitive Dysfunction3
Dyskinesias3
Parkinsonian Disorders3
Disease2
Genetic Predisposition to Disease1
Mental Disorders1
Metabolic Syndrome1
Recurrence1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.